Apparent decrease in population clearance of theophylline: implications for dosage (Q73924014)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9390104%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

title

Apparent decrease in population clearance of theophylline: implications for dosage (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9390104%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9390104%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

author name string

Weinberger MM

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9390104%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

Milavetz G

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9390104%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

Marshik P

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9390104%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

Teresi ME

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9390104%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

Hendeles L

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9390104%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

publication date

1 November 1997

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9390104%20AND%20SRC:MED&resulttype=core&format=json

Clinical Pharmacology & Therapeutics

7 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9390104%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

volume

62

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9390104%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9390104%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

page(s)

483-489

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9390104%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

cites work

Theophylline in asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990043-6

Oral theophylline dosage for the management of chronic asthma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990043-6

Rational Intravenous Doses of Theophylline

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990043-6

Immunomodulation by theophylline in asthma. Demonstration by withdrawal of therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990043-6

Anti-inflammatory effects of low-dose oral theophylline in atopic asthma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990043-6

Evaluation of oral bronchodilator therapy in asthmatic children. Bronchodilators in asthmatic children.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990043-6

Clinical and bronchodilating efficacy of controlled-release theophylline as a function of its serum concentrations in preschool children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990043-6

Evaluation of a scheme for establishing and maintaining dosage of theophylline in ambulatory patients with chronic asthma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990043-6

Current concepts. Slow-release theophylline rationale and basis for product selection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990043-6

Multicentre evaluation of disposable visual measuring device to assay theophylline from capillary blood sample

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990043-6

Comparison of theophylline blood levels measured by the standard TDx assay and a new patient-side immunoassay cartridge system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990043-6

Relationship of theophylline clearance to oral dosage in children with chronic asthma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990043-6

Stability of theophylline elimination rate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990043-6

Altered theophylline pharmacokinetics during acute respiratory viral illness

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990043-6

Theophylline pharmacokinetics and respiratory infections

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990043-6

Theophylline pharmacokinetics during respiratory viral infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990043-6

Theophylline disposition in patients with hepatic cirrhosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990043-6

Pharmacokinetics of theophylline in hepatic disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990043-6

Influence of dietary protein and carbohydrate on antipyrine and theophylline metabolism in man

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990043-6

Effect of charcoal-broiled beef on antipyrine and theophylline metabolism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990043-6

Theophylline pharmacokinetics in advanced age

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990043-6

Pharmacokinetic interactions between theophylline and other medication (Part I).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990043-6

Pharmacokinetic Interactions Between Theophylline and Other Medication (Part II)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990043-6

Theophylline kinetics in relation to age: the importance of smoking

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990043-6

Effect of prednisolone on theophylline pharmacokinetics in patients with chronic airflow obstruction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990043-6

Influence of methylxanthine-containing foods on theophylline metabolism and kinetics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990043-6

Trends in cigarette smoking in the United States. Projections to the year 2000.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990043-6

Effects of passive smoking on theophylline clearance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990043-6

Theophylline pharmacokinetics in black Zimbabwean males

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990043-6

10.1016/S0009-9236(97)90043-6

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9390104%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

1 reference